12-Month Real-World Safety & Efficacy of Lecanemab in Early Alzheimer's Disease
NCT07034222
·
clinicaltrials.gov ↗
PHASE4
Phase
ACTIVE_NOT_RECRUITING
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Alzheimer's Disease(AD)
Interventions
DRUG:
Administer Leqemi 10 mg/kg, every two weeks.
Sponsor
Ruijin Hospital